Simon Graindorge

Non Executive Director

Simon has spent over 15 years in the healthcare industry, having significant experience as an investor, and also as an entrepreneur in leadership roles at start-up companies. He is currently a Partner in IP Group’s Life Sciences team, where he leads investments in medical and digital healthcare technologies which will significantly impact patient access, improve outcomes and save healthcare costs. Over the last decade he has invested in and helped build companies such as Tissue Regenix Group plc, Creavo Medical Technologies, Oxehealth, Intelligent Ultrasound (acquired by Medaphor Group), Pancregenesis. Simon joined IP Group from Ceramex Ltd, a corporate spin-out of the Hexadex Group where his role as Operations Director covered all operational, product development and R&D aspects. Simon holds a PhD in Biomedical Engineering from the University of Western Australia, as well as Bachelor degrees in both Mechanical Engineering and Chemistry, and is also a Chartered Engineer.